PURPOSE: We analysed 11 patients with malignant musculoskeletal tumours of the humerus who underwent limb salvage surgery with total humeral custom endoprosthesis from 1990 to 2009. METHODS: There were six male and five female patients, with a mean age of 17 years. The most common diagnosis was osteosarcoma. The average follow-up period was 66 months, with the maximum being 180 months. Functional and oncological outcomes were analysed. RESULTS: The one and five year cumulative survival (Kaplan-Meier method) rates were 90.9% and 77.9 %. The average Musculoskeletal Tumour Society Score (MSTS) was 80%. Two patients died due to metastasis. One patient had a forequarter amputation for local recurrence. The procedure provides fast recovery and relatively good restoration of elbow function, whereas active shoulder movements remain limited CONCLUSION: Total humeral custom endoprosthetic replacement represents a viable treatment option in indicated patients, providing reliable and reasonable function of the upper limb, with a low complication rate.
PURPOSE: We analysed 11 patients with malignant musculoskeletal tumours of the humerus who underwent limb salvage surgery with total humeral custom endoprosthesis from 1990 to 2009. METHODS: There were six male and five female patients, with a mean age of 17 years. The most common diagnosis was osteosarcoma. The average follow-up period was 66 months, with the maximum being 180 months. Functional and oncological outcomes were analysed. RESULTS: The one and five year cumulative survival (Kaplan-Meier method) rates were 90.9% and 77.9 %. The average Musculoskeletal Tumour Society Score (MSTS) was 80%. Two patients died due to metastasis. One patient had a forequarter amputation for local recurrence. The procedure provides fast recovery and relatively good restoration of elbow function, whereas active shoulder movements remain limited CONCLUSION: Total humeral custom endoprosthetic replacement represents a viable treatment option in indicated patients, providing reliable and reasonable function of the upper limb, with a low complication rate.
Authors: U Lenze; C Knebel; F Lenze; S Consalvo; I Lazic; S Breden; H Rechl; R von Eisenhart-Rothe Journal: Orthopade Date: 2019-07 Impact factor: 1.087
Authors: Jan Schmolders; Sebastian Koob; Paul Schepers; Michael Kehrer; Sönke Percy Frey; Dieter Christian Wirtz; Peter Heinrich Pennekamp; Andreas Christian Strauss Journal: Int Orthop Date: 2016-11-09 Impact factor: 3.075
Authors: Hazem Wafa; Krishna Reddy; Robert Grimer; Adesegun Abudu; Lee Jeys; Simon Carter; Roger Tillman Journal: Clin Orthop Relat Res Date: 2015-03 Impact factor: 4.176
Authors: Kristian Nikolaus Schneider; Jan Niklas Bröking; Georg Gosheger; Timo Lübben; Jendrik Hardes; Dominik Schorn; Maria Anna Smolle; Christoph Theil; Dimosthenis Andreou Journal: Clin Orthop Relat Res Date: 2021-08-01 Impact factor: 4.755
Authors: Dung Trung Tran; Thanh Duc Tran; Son Ba Nguyen; Sang Quang Tran Nguyen; Quang Minh Dang; Cong Van Tran Journal: Case Rep Oncol Date: 2022-01-13
Authors: Christoph Theil; Jan Schwarze; Georg Gosheger; Burkhard Moellenbeck; Kristian Nikolaus Schneider; Niklas Deventer; Sebastian Klingebiel; George Grammatopoulos; Friedrich Boettner; Tom Schmidt-Braekling Journal: Cancers (Basel) Date: 2022-01-11 Impact factor: 6.639